Company Profiles

driven by the PitchBook Platform

Adgero Biopharmaceuticals

Description

Developer of a late stage photodynamic therapy platform designed for the treatment of serious oncology indications. The company's platform uses photosensitizers that, when exposed to light, act as a catalyst to produce a form of oxygen that induces local tumor cell death enabling doctors to treat serious oncology indications.

2007

Founded

PRIVATE

Status

1-10

Employees

Corporate

Latest Deal Type

$2M

Latest Deal Amount

$14.8M

Total Amount Raised

Description

Developer of a late stage photodynamic therapy platform designed for the treatment of serious oncology indications. The company's platform uses photosensitizers that, when exposed to light, act as a catalyst to produce a form of oxygen that induces local tumor cell death enabling doctors to treat serious oncology indications.

Website:

www.adgerobiopharm.com

Ownership Status

Privately held (backing)

Financing Status

Angel-Backed

Primary Industry

Biotechnology

Other Industries

Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology

Primary Office

3 Davenport Drive Princeton Junction, NJ 08850United States +1 (908) 996-0239
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Adgero Biopharmaceuticals's full profile, request a free trial.

Adgero Biopharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Adgero Biopharmaceuticals Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalCorporationMinority000 0000000 0000
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Corporation

Adgero Biopharmaceuticals Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Jane MaidaChief Financial Officer
Frank Pilkiewicz Ph.DFounder & Chairman, Chief Executive Officer & President
Laura Edgerly-PflugVice President, Manufacturing Operations and Quality Control
Steve Rychnovsky Ph.DVice President, Operations & Product Development
Jane Maida Chief Financial Officer
Frank Pilkiewicz Ph.D Founder & Chairman, Chief Executive Officer & President
Laura Edgerly-Pflug Vice President, Manufacturing Operations and Quality Control
Steve Rychnovsky Ph.D Vice President, Operations & Product Development

Adgero Biopharmaceuticals Board Members (5)

NameRepresentingRoleSinceContact
Info
Allen BloomAdgero BiopharmaceuticalsBoard Member000 0000
David HochmanAdgero BiopharmaceuticalsBoard Member000 0000
Frank Pilkiewicz Ph.DAdgero BiopharmaceuticalsFounder & Chairman, Chief Executive Officer & President000 0000
Roman Perez-Soler MDSelfBoard Member000 0000
Tim McInerneyAdgero BiopharmaceuticalsBoard Member000 0000
Allen Bloom Board Member Adgero Biopharmaceuticals
David Hochman Board Member Adgero Biopharmaceuticals
Frank Pilkiewicz Ph.D Founder & Chairman, Chief Executive Officer & President Adgero Biopharmaceuticals
Roman Perez-Soler MD Board Member Self
Tim McInerney Board Member Adgero Biopharmaceuticals
Request full access to PitchBook